ATE24910T1 - 4-aryl- oder heteroaryl-thio-2-oxo-1azetidinsulfons|uresalzeund verfahren zu deren herstellung. - Google Patents

4-aryl- oder heteroaryl-thio-2-oxo-1azetidinsulfons|uresalzeund verfahren zu deren herstellung.

Info

Publication number
ATE24910T1
ATE24910T1 AT82105647T AT82105647T ATE24910T1 AT E24910 T1 ATE24910 T1 AT E24910T1 AT 82105647 T AT82105647 T AT 82105647T AT 82105647 T AT82105647 T AT 82105647T AT E24910 T1 ATE24910 T1 AT E24910T1
Authority
AT
Austria
Prior art keywords
alkyl
aryl
oxo
preparation
thiadiazol
Prior art date
Application number
AT82105647T
Other languages
English (en)
Inventor
Uwe D Treuner
Theodor Denzel
Hermann Breuer
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of ATE24910T1 publication Critical patent/ATE24910T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT82105647T 1981-06-29 1982-06-25 4-aryl- oder heteroaryl-thio-2-oxo-1azetidinsulfons|uresalzeund verfahren zu deren herstellung. ATE24910T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27813181A 1981-06-29 1981-06-29
EP82105647A EP0068466B1 (de) 1981-06-29 1982-06-25 4-Aryl- oder Heteroaryl-thio-2-oxo-1-azetidinsulfonsäuresalze und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
ATE24910T1 true ATE24910T1 (de) 1987-01-15

Family

ID=23063794

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82105647T ATE24910T1 (de) 1981-06-29 1982-06-25 4-aryl- oder heteroaryl-thio-2-oxo-1azetidinsulfons|uresalzeund verfahren zu deren herstellung.

Country Status (4)

Country Link
EP (1) EP0068466B1 (de)
JP (1) JPS588060A (de)
AT (1) ATE24910T1 (de)
DE (1) DE3275092D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX7096E (es) * 1980-12-05 1987-06-19 Takeda Chemical Industries Ltd Metodo para preparacion de derivados de 2-oxoazetidina
JPS58210060A (ja) * 1982-05-31 1983-12-07 Takeda Chem Ind Ltd 2−オキソアゼチジン誘導体、その製造法および用途
FR2539128A1 (fr) * 1983-01-10 1984-07-13 Roussel Uclaf Nouveaux derives de la 3-amino 2-oxoazetidine comportant en position 1 un radical heterocyclique azote, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation
US5137884A (en) * 1983-11-16 1992-08-11 Merck & Co., Inc. N-tetrazolyl beta-lactams
DE3342929A1 (de) * 1983-11-26 1985-06-05 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel
US4918185A (en) * 1984-05-22 1990-04-17 Eli Lilly And Company Process for carbon-carbon bond formation at the C-4 position of 3-acylaminoazetidinones and products and starting materials therefor
US4771135A (en) * 1984-05-22 1988-09-13 Eli Lilly And Company Process for carbon-carbon bond formation at the C-4 position of 3-acylaminoazetidinones and products and starting materials therefor
CA1249279A (en) * 1984-05-22 1989-01-24 Larry C. Blaszczak Process for carbon-carbon bond formation at the c-4 position of 3-acylaminoazetidinones
JPH04120123U (ja) * 1991-04-09 1992-10-27 アルパイン株式会社 トランジスタ定電圧回路

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1503638A (en) * 1974-02-26 1978-03-15 Ciba Geigy Ag Process for the manufacture of 3-methylenebutyric acid derivatives
US4174323A (en) * 1977-06-09 1979-11-13 Smithkline Corporation 1-(2-Sulfamidoethyl)-1,4-dihydro-5H-tetrazole-5-thione
MX7096E (es) * 1980-12-05 1987-06-19 Takeda Chemical Industries Ltd Metodo para preparacion de derivados de 2-oxoazetidina

Also Published As

Publication number Publication date
EP0068466B1 (de) 1987-01-14
JPS588060A (ja) 1983-01-18
EP0068466A1 (de) 1983-01-05
DE3275092D1 (en) 1987-02-19

Similar Documents

Publication Publication Date Title
AU1214383A (en) Pyridine derivatives
ATE24910T1 (de) 4-aryl- oder heteroaryl-thio-2-oxo-1azetidinsulfons|uresalzeund verfahren zu deren herstellung.
KR880001570A (ko) 나프탈렌 유도체
KR880001674A (ko) 세팔로스포린 화합물, 그 제조 방법 및 항세균제
KR860002511A (ko) 세팔로스포린 화합물의 제조방법
SE8003820L (sv) Nya 3-tiovinylcefalosporiner, forfaranden for framstellning av desamma och farmaceutiska kompositioner innehallande desamma
AU557096B2 (en) Thiazole derivatives
KR920007987A (ko) 니트로구아니딘 유도체의 제조 방법
DK37691A (da) Substituerede beta-diketoner, farmaceutiske midler indeholdende disse forbindelser samt anvendelse deraf
DK288686A (da) Farmaceutiske praeparater
KR840005816A (ko) 세팜로스포틴 화합물의 제조방법
MA20109A1 (fr) Procede de preparation de composes de cepheme
ATE67199T1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
AU6518980A (en) Benzothiazole derivatives
ATE15045T1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
EP0127541A3 (en) Salts of amino-beta-lactamic acids and process for the preparation thereof
ES8100299A1 (es) Un procedimiento para preparar un semi-acido-sal cristalino de un derivado de cefalosporina
DE3880092D1 (de) Antibiotika der mureidomycin-gruppe, deren herstellung und deren verwendung.
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
AU561008B2 (en) N,n,-disubstituted alkenamides and phenylalkenamides and heterocyclic starting compounds
ES8505177A1 (es) Procedimiento para la obtencion de un nuevo derivado del acido tiolactico
GR79651B (de)
KR880000490B1 (en) 1-oxa-l-dethia-cephalosporin compounds and antibacterial agent comprising the same
SE8005260L (sv) Nya isokinolinderivat samt framstellning derav
IE45548L (en) Pyridazinyl thiomethyl cephalosporins.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee